Ondansetron Spirig HC 8 mg, Schmelztabletten - 10 Swissmedic Key 69841003 Registration Holder Spirig HealthCare AG Name Ondansetron Spirig HC 8 mg, Schmelztabletten Date of registration 08.05.2025 Introduction of Sequence 08.05.2025 ATC-Classification Ondansetron (A04AA01) Revision date WHO WHO-DDD Valid until 07.05.2030 Index Therapeuticus (BSV) Show package size 10 Index Therapeuticus (Swissmedic) 01.09. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680698410034 Medication Code Synthetika Pharmacode Disponibility
Composition ondansetronum 8 mg, mannitolum, silica colloidalis anhydrica, copolymerum methacrylatis butylati basicum, crospovidonum, aspartamum 6 mg, aromatica (Erdbeer) cum alcohol benzylicus, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Melting tablets Active Agent Dose Ondansetron 8 mg
Inactive agents Dose Aromatica (Erdbeer) cum Alcohol Benzylicus Aspartame 6 mg Copolymerum Methacrylatis Butylati Basicum Crospovidonum Magnesii Stearas Mannitol Pro Compresso Silica Colloidalis Anhydrica
Source Data was imported : 06.06.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :